2023 Q4 Form 10-K Financial Statement

#000121390024018566 Filed on February 29, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022
Revenue $42.72K $207.5K
YoY Change
Cost Of Revenue $399.1K $1.730M $1.148M
YoY Change 50.66%
Gross Profit -$356.4K -$1.523M -$1.041M
YoY Change 46.33%
Gross Profit Margin -834.22% -733.68%
Selling, General & Admin $2.509M $5.224M $576.8K
YoY Change 805.56% -83.66%
% of Gross Profit
Research & Development $2.712M $9.947M $13.57M
YoY Change -26.67% 91.27%
% of Gross Profit
Depreciation & Amortization $467.0K $1.864M $388.1K
YoY Change 380.22% 813.91%
% of Gross Profit
Operating Expenses $4.996M $19.20M $19.91M
YoY Change -3.55% 87.46%
Operating Profit -$5.352M -$20.73M -$51.35K
YoY Change 40262.2% -5.99%
Interest Expense -$242.4K $2.264M $636.3K
YoY Change 255.86% -105.76%
% of Operating Profit
Other Income/Expense, Net $0.00 -$4.086M -$902.1K
YoY Change 352.97%
Pretax Income -$7.063M -$24.81M -$21.86M
YoY Change 13.54% 0.88%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$7.063M -$24.81M -$51.35K
YoY Change 48218.99% -5.99%
Net Earnings / Revenue -16534.15% -11955.83%
Basic Earnings Per Share -$1.75 -$0.01
Diluted Earnings Per Share -$0.19 -$1.75 -$0.01
COMMON SHARES
Basic Shares Outstanding 24.83M shares 14.20M shares 5.000M shares
Diluted Shares Outstanding 14.20M shares 5.000M shares

Balance Sheet

Concept 2023 Q4 2023 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.760K $6.760K $2.716M
YoY Change -99.75% -65.91%
Cash & Equivalents $6.756K
Short-Term Investments
Other Short-Term Assets $677.0K $677.0K $81.34K
YoY Change 732.27% 628.85%
Inventory $774.3K $774.4K $618.3K
Prepaid Expenses $677.0K
Receivables $2.955K $2.960K $23.70K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.461M $1.461M $3.439M
YoY Change 319600.0% -57.52% -59.26%
LONG-TERM ASSETS
Property, Plant & Equipment $48.42K $830.9K $4.592M
YoY Change -98.57% -81.91% 3739.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $512.7K $512.7K $512.7K
YoY Change 0.0% 430.43%
Total Long-Term Assets $1.344M $1.344M $5.105M
YoY Change -73.68% 2260.61%
TOTAL ASSETS
Total Short-Term Assets $1.461M $1.461M $3.439M
Total Long-Term Assets $1.344M $1.344M $5.105M
Total Assets $2.805M $2.805M $8.544M
YoY Change 613586.87% -67.18% -1.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.051M $2.051M $162.0K
YoY Change 20406.05% 1165.57% -51.82%
Accrued Expenses $255.8K $752.8K $520.6K
YoY Change 583.47% 44.6%
Deferred Revenue $0.00
YoY Change
Short-Term Debt $70.00K $70.00K $0.00
YoY Change
Long-Term Debt Due $3.364M $3.364M $3.214M
YoY Change 4.65%
Total Short-Term Liabilities $6.237M $6.237M $3.897M
YoY Change 4930.02% 60.05% 1058.75%
LONG-TERM LIABILITIES
Long-Term Debt $230.9K $230.9K $3.078M
YoY Change -92.5%
Other Long-Term Liabilities $369.8K $369.8K $14.02M
YoY Change -97.36%
Total Long-Term Liabilities $600.7K $600.7K $17.10M
YoY Change -96.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.237M $6.237M $3.897M
Total Long-Term Liabilities $600.7K $600.7K $17.10M
Total Liabilities $6.838M $6.838M $21.00M
YoY Change 5414.48% -67.43% 6143.11%
SHAREHOLDERS EQUITY
Retained Earnings -$68.33M
YoY Change 54989.27%
Common Stock $2.450K
YoY Change 390.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.033M -$4.033M -$12.45M
YoY Change
Total Liabilities & Shareholders Equity $2.805M $2.805M $8.544M
YoY Change 613586.87% -67.18% -1.3%

Cashflow Statement

Concept 2023 Q4 2023 2022
OPERATING ACTIVITIES
Net Income -$7.063M -$24.81M -$51.35K
YoY Change 48218.99% -5.99%
Depreciation, Depletion And Amortization $467.0K $1.864M $388.1K
YoY Change 380.22% 813.91%
Cash From Operating Activities -$3.677M -$15.97M -$48.85K
YoY Change 32591.03% -5.37%
INVESTING ACTIVITIES
Capital Expenditures $2.420K $4.914K $3.645M
YoY Change -99.87% 2148.72%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$416.0K
YoY Change -100.0% 330.43%
Cash From Investing Activities -$2.420K -$4.914K -$4.061M
YoY Change -99.88% 1469.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 183.6K $13.27M $49.04K
YoY Change 26953.08% 15.5%
NET CHANGE
Cash From Operating Activities -3.677M -$15.97M -$48.85K
Cash From Investing Activities -2.420K -$4.914K -$4.061M
Cash From Financing Activities 183.6K $13.27M $49.04K
Net Change In Cash -3.495M -$2.709M $186.00
YoY Change -1456531.72% -102.03%
FREE CASH FLOW
Cash From Operating Activities -$3.677M -$15.97M -$48.85K
Capital Expenditures $2.420K $4.914K $3.645M
Free Cash Flow -$3.679M -$15.98M -$3.694M
YoY Change 332.5% 1628.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6896769 shares
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-56237
CY2023 dei Entity Registrant Name
EntityRegistrantName
SERVE ROBOTICS INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3844872
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
730 Broadway
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Redwood City
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94063
CY2023 dei City Area Code
CityAreaCode
(818)
CY2023 dei Local Phone Number
LocalPhoneNumber
860-1352
CY2023 dei Security12b Title
Security12bTitle
None
CY2023 dei No Trading Symbol Flag
NoTradingSymbolFlag
true
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24832814 shares
CY2023 dei Auditor Firm
AuditorFirmId
3501
CY2023 dei Auditor Name
AuditorName
dbbmckennon
CY2023 dei Auditor Location
AuditorLocation
Newport Beach, California
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6756 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2715719 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2955 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23697 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
774349 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
618262 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
676969 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
81339 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1461029 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
3439017 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48422 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3376427 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
782439 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1215968 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
512659 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
512659 usd
CY2023Q4 us-gaap Assets
Assets
2804549 usd
CY2022Q4 us-gaap Assets
Assets
8544071 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2050605 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
162034 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
255849 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37434 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1000000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1000000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
496963 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
483186 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2363807 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2214348 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6237224 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3897002 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
230933 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1214600 usd
CY2022Q4 patr Simple Agreements For Future Equity
SimpleAgreementsForFutureEquity
13150745 usd
CY2023Q4 patr Restricted Stock Award Liability
RestrictedStockAwardLiability
158617 usd
CY2022Q4 patr Restricted Stock Award Liability
RestrictedStockAwardLiability
162747 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
211181 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
708143 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1862980 usd
CY2023Q4 us-gaap Liabilities
Liabilities
6837955 usd
CY2022Q4 us-gaap Liabilities
Liabilities
20996217 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24832814 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7161654 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24508795 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6826352 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2450 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
683 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64468141 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31232737 usd
CY2023Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
169616 usd
CY2022Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
165719 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68334381 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43520645 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-4033406 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-12452146 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2804549 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8544071 usd
CY2023 us-gaap Revenues
Revenues
207545 usd
CY2022 us-gaap Revenues
Revenues
107819 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
1730262 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
1148426 usd
CY2023 us-gaap Gross Profit
GrossProfit
-1522717 usd
CY2022 us-gaap Gross Profit
GrossProfit
-1040607 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4618499 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3786124 usd
CY2023 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2564930 usd
CY2022 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2035063 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9947258 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13565765 usd
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
605205 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
525494 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1468995 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
19204887 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
19912446 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-20727604 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-20953053 usd
CY2023 us-gaap Interest Expense
InterestExpense
2264426 usd
CY2022 us-gaap Interest Expense
InterestExpense
636330 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
149000 usd
CY2023 patr Change In Fair Value Of Simple Agreements For Future Equity
ChangeInFairValueOfSimpleAgreementsForFutureEquity
1672706 usd
CY2022 patr Change In Fair Value Of Simple Agreements For Future Equity
ChangeInFairValueOfSimpleAgreementsForFutureEquity
265744 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4086132 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-902074 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-24813736 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-21855127 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14204078 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6896769 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.75
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.17
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
8320395 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
999999 usd
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
161469 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
49000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
195056 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-21855127 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-12452146 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
12160560 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
3751875 usd
CY2023 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
17490404 usd
CY2023 patr Issuance Of Common Stock Pursuant To Private Placement Offering Net Of Offering Costs
IssuanceOfCommonStockPursuantToPrivatePlacementOfferingNetOfOfferingCosts
574124 usd
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-9838 usd
CY2023 patr Stock Issued During Period Value Restricted Stock Awards Repurchased
StockIssuedDuringPeriodValueRestrictedStockAwardsRepurchased
-3 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
991000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
544375 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2289697 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-24813736 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-4033406 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-24813736 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-21855127 usd
CY2023 us-gaap Depreciation
Depreciation
1863924 usd
CY2022 us-gaap Depreciation
Depreciation
388139 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
544375 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
195056 usd
CY2023 patr Change In Fair Value Of Simple Agreement For Future Equity
ChangeInFairValueOfSimpleAgreementForFutureEquity
1672706 usd
CY2022 patr Change In Fair Value Of Simple Agreement For Future Equity
ChangeInFairValueOfSimpleAgreementForFutureEquity
265744 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1811798 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
13600 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
149000 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1468995 usd
CY2023 patr Interest On Recourse Loan
InterestOnRecourseLoan
3897 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20742 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23697 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
156087 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
154840 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
595630 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
81339 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-11163 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1888568 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-174278 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
228020 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
37434 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-49656 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-24641 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15970878 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21402786 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4914 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3644950 usd
CY2022 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
416012 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4914 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4060962 usd
CY2023 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2666953 usd
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
12885001 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
750000 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2500000 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1750000 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
250000 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2798410 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
519000 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
449000 usd
CY2022 patr Proceeds From Lease Liability Financing
ProceedsFromLeaseLiabilityFinancing
4455852 usd
CY2023 patr Repayment Of Lease Liability Financing
RepaymentOfLeaseLiabilityFinancing
1713518 usd
CY2022 patr Repayment Of Lease Liability Financing
RepaymentOfLeaseLiabilityFinancing
378524 usd
CY2023 patr Issuance Of Restricted Common Stock Net Of Repurchases
IssuanceOfRestrictedCommonStockNetOfRepurchases
-3 usd
CY2022 patr Issuance Of Restricted Common Stock Net Of Repurchases
IssuanceOfRestrictedCommonStockNetOfRepurchases
1278 usd
CY2023 patr Issuance Of Common Stock Pursuant To Merger And Private Placement Net Of Offering Costs
IssuanceOfCommonStockPursuantToMergerAndPrivatePlacementNetOfOfferingCosts
10444987 usd
CY2022 patr Issuance Of Series Seed Preferred Stock
IssuanceOfSeriesSeedPreferredStock
999999 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13266829 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20213606 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations
-2708963 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations
-5250142 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2715719 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7965861 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6756 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2715719 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
507193 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
622730 usd
CY2022 patr Restricted Stock Awards Liability
RestrictedStockAwardsLiability
162747 usd
CY2023 patr Derivative Liability In Connection With Convertible Note
DerivativeLiabilityInConnectionWithConvertibleNote
601000 usd
CY2023 patr Debt Discount Issued As Accrued Liability
DebtDiscountIssuedAsAccruedLiability
63840 usd
CY2023 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
17490404 usd
CY2023 patr Conversion Of Convertible Note And Derivative Into Common Stock In Connection With Merger
ConversionOfConvertibleNoteAndDerivativeIntoCommonStockInConnectionWithMerger
3751875 usd
CY2023 patr Warrants Issued In Connection With Note Payable
WarrantsIssuedInConnectionWithNotePayable
991000 usd
CY2022 patr Warrants Issued In Connection With Note Payable
WarrantsIssuedInConnectionWithNotePayable
49000 usd
CY2022 patr Subscription Receivable
SubscriptionReceivable
165719 usd
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0in"> </td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NATURE OF OPERATIONS, HISTORY, ORGANIZATION AND BUSINESS</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Serve Operating Co. (formerly known as Serve Robotics Inc.) (the “Company” or “Serve”) is a corporation formed on January 15, 2021 under the laws of the State of Delaware. The Company is developing next generation robots for last-mile delivery services. The Company is headquartered in Redwood City, California.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">In February 2021, the Company entered into a contribution and license agreement with Postmates, LLC, a Delaware limited liability company (“Postmates”). Pursuant to the agreement, Postmates transferred over certain contracts and agreements, intellectual property and patents and hardware and equipment to the Company. As the contribution was without consideration, the agreement did not have any effect on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On July 31, 2023, Patricia’s wholly-owned subsidiary, Serve Acquisition Corp., a corporation formed in the State of Delaware on July 10, 2023 (“Acquisition Sub”), merged with and into the Company. Pursuant to this transaction (the “Merger”), the Company was the surviving corporation and became Patricia’s wholly owned subsidiary, and all of the outstanding stock of Serve was converted into shares of Patricia’s common stock. All of Serve’s outstanding warrants and options were assumed by Patricia. In addition, on July 31, 2023, the board of directors of Patricia Acquisition Corp., a Delaware corporation incorporated on November 9, 2020 (“Patricia”) and all of its pre-Merger stockholders approved a restated certificate of incorporation, which was effective upon its filing with the Secretary of State of the State of Delaware on July 31, 2023, and through which Patricia changed its name to “Serve Robotics Inc.” Following the consummation of the Merger, Serve changed its name to “Serve Operating Co.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As a result of the Merger, Patricia acquired the business of Serve and will continue the existing business operations of Serve as a public reporting company under the name Serve Robotics Inc. In accordance with “reverse merger” or “reverse acquisition” accounting treatment, the Company was determined the accounting acquirer. Patricia’s historical financial statements before the Merger has been replaced with the historical financial statements of Serve before the Merger in filings with the SEC since the Merger unless otherwise noted.</p>
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-24813736 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-21855127 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15970878 usd
CY2023 patr Proceeds From Convertible Promissory Note
ProceedsFromConvertiblePromissoryNote
5000000 usd
CY2023 us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
As a result of the Merger, each of Serve’s shares of capital stock issued and outstanding immediately prior to the closing of the Merger was converted into the right to receive 0.8035 shares of Patricia’s common stock (the “Common Share Conversion Ratio”).
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, impairment of long-lived assets, right-of-use assets and liabilities, stock-based compensation and allocation of costs of revenue. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates. </p>
CY2023 patr Branding Fees
BrandingFees
45250 usd
CY2023 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
15833 usd
CY2022 patr Delivery Revenue
DeliveryRevenue
54423 usd
CY2022 patr Branding Fees
BrandingFees
53575 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b><i>Concentrations of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company generally maintains balances in various operating accounts at financial institutions that management believes to be of high credit quality, in amounts that may exceed federally insured limits. The Company has not experienced any losses related to its cash and cash equivalents and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. As of December 31, 2023 and 2022, the Company’s cash and cash equivalents were held at one accredited financial institution.</p>
CY2023Q4 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P2Y
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1468995 usd
CY2023 patr Delivery Revenue
DeliveryRevenue
146462 usd
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
184000 usd
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
128000 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2929677 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9022947 shares
CY2023Q4 us-gaap Preferred Stock Convertible Shares Issuable
PreferredStockConvertibleSharesIssuable
7978616 shares
CY2023Q4 patr Preferred Stock Converted Into Warrants
PreferredStockConvertedIntoWarrants
128819 shares
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
4
CY2023 patr Percentage Of Probability Of Liquidity And Equity Financing
PercentageOfProbabilityOfLiquidityAndEquityFinancing
1 pure
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
12885001 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
265744 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
13150745 usd
CY2023 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2666953 usd
CY2023 patr Issuance Of Embedded Derivative Liability
IssuanceOfEmbeddedDerivativeLiability
601000 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
1821706 usd
CY2023 patr Conversion To Common Stock Before Apo
ConversionToCommonStockBeforeAPO
-18240404 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2342954 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3807035 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2294532 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
430608 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48422 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3376427 usd
CY2023 us-gaap Depreciation
Depreciation
1863924 usd
CY2022 us-gaap Depreciation
Depreciation
388139 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1468995 usd
CY2023Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1000000 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
250000 usd
CY2023 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
17518 shares
CY2023Q4 us-gaap Notes Payable
NotesPayable
19067 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
35400 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
750000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual Percent Past Due
FinancingReceivableExcludingAccruedInterestNonaccrualPercentPastDue
0.18 pure
CY2023Q2 us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
203090 usd
CY2023 patr Contingent Warrants Issued Conversion Charges
ContingentWarrantsIssuedConversionCharges
991000 usd
CY2023 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
449000 usd
CY2023Q3 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.0767 pure
CY2023 us-gaap Proceeds From Commissions Received
ProceedsFromCommissionsReceived
70000 usd
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0767 pure
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
12885001 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
65000000 usd
CY2022 patr Valuation Cap Discount Rate Percentage
ValuationCapDiscountRatePercentage
0.80 pure
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
2300000 usd
CY2022 patr Valuation Uncapped Discount Rate Percentage
ValuationUncappedDiscountRatePercentage
0.90 pure
CY2022 patr Agreement Discount Rate
AgreementDiscountRate
0.80 pure
CY2023 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2666953 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
65000000 usd
CY2023 patr Agreement Discount Rate
AgreementDiscountRate
0.80 pure
CY2023Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
0 usd
CY2022Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
13150745 usd
CY2022Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
22624909 usd
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
257639 shares
CY2022Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
999999 usd
CY2023 patr Convertible Note And Related Derivative Liability Converted Shares Of Common Stock
ConvertibleNoteAndRelatedDerivativeLiabilityConvertedSharesOfCommonStock
937961 shares
CY2023Q4 us-gaap Preferred Stock Convertible Shares Issuable
PreferredStockConvertibleSharesIssuable
7978616 shares
CY2023Q4 patr Issuance Of Common Stock Pursuant To Private Placement Offering Net Of Offering Costsin Shares
IssuanceOfCommonStockPursuantToPrivatePlacementOfferingNetOfOfferingCostsinShares
143531 shares
CY2023Q4 patr Common Stock Gross Proceeds
CommonStockGrossProceeds
547123 usd
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4
CY2023Q4 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
529127 usd
CY2023 patr Shares Of Restricted Common Stock Issued
SharesOfRestrictedCommonStockIssued
338121 shares
CY2023 patr Restricted Common Stock For Recourse Notes
RestrictedCommonStockForRecourseNotes
164116 usd
CY2023 us-gaap Restricted Stock Shares Issued Net Of Shares For Tax Withholdings
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
158617 shares
CY2022 us-gaap Restricted Stock Shares Issued Net Of Shares For Tax Withholdings
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
162747 shares
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Vesting Number
SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
6842490 shares
CY2023 patr Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Un Vesting Number
SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedUnVestingNumber
2877761 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y7M6D
CY2023 patr Stock Based Compensation Pertaining To Vesting Of Restricted Common Stock
StockBasedCompensationPertainingToVestingOfRestrictedCommonStock
263893 usd
CY2022 patr Stock Based Compensation Pertaining To Vesting Of Restricted Common Stock
StockBasedCompensationPertainingToVestingOfRestrictedCommonStock
141446 usd
CY2023 patr Repurchased Restricted Stock Awards
RepurchasedRestrictedStockAwards
319118 shares
CY2022 patr Repurchased Restricted Stock Awards
RepurchasedRestrictedStockAwards
287591 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
250000 shares
CY2023 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
0.001
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
590073 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.49
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
639682 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.49
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
368446 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
861309 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.49
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
765477 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.75
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
111400 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.6
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1515386 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.61
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5111928 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
722264 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.66
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2413853 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1515386 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.61
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
5111928 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0298 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.75 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.791 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.41
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.27
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
544375 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
195056 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14412164 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9026439 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11896550 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8940441 usd
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
2516557 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-943 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
85998 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14412164 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9026439 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
5385725 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
6043682 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.28 pure
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
42321416 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
31805199 usd
CY2023 patr Lease Expiring Term
LeaseExpiringTerm
August 31, 2025
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
933661 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
621388 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
550470 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
381457 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1535230 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0725 pure
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0725 pure
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
527983000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
214775000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
742758000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
34614000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
708144000 usd
CY2023 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
4455852 usd
CY2023 us-gaap Repayments Of Debt
RepaymentsOfDebt
1713521 usd
CY2022 us-gaap Repayments Of Debt
RepaymentsOfDebt
378524 usd
CY2023 us-gaap Liabilities Average Amount Outstanding
LiabilitiesAverageAmountOutstanding
2363807 usd
CY2022 us-gaap Liabilities Average Amount Outstanding
LiabilitiesAverageAmountOutstanding
4077328 usd
CY2023Q4 us-gaap Property Plant And Equipment Salvage Value Percentage
PropertyPlantAndEquipmentSalvageValuePercentage
0.45 pure
CY2023 us-gaap Public Utilities Property Plant And Equipment Interest Rate On Intermediary Debt For Electric Utility Plant Construction
PublicUtilitiesPropertyPlantAndEquipmentInterestRateOnIntermediaryDebtForElectricUtilityPlantConstruction
0.20 pure
CY2023Q4 us-gaap Purchase Obligation
PurchaseObligation
2300000 usd
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Security Exchange Name
SecurityExchangeName
NONE
CY2023Q4 patr Simple Agreements For Future Equity
SimpleAgreementsForFutureEquity
usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14204078 shares
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.75
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.17
CY2022 patr Stock Issued During Period Value Restricted Stock Awards Repurchased
StockIssuedDuringPeriodValueRestrictedStockAwardsRepurchased
usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2023 patr Patricia Shares Converted Into Common Stock Upon The Merger
PatriciaSharesConvertedIntoCommonStockUponTheMerger
usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
usd
CY2022 patr Interest On Recourse Loan
InterestOnRecourseLoan
usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
usd
CY2023 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2023 patr Proceeds From Lease Liability Financing
ProceedsFromLeaseLiabilityFinancing
usd
CY2022 patr Issuance Of Common Stock Pursuant To Merger And Private Placement Net Of Offering Costs
IssuanceOfCommonStockPursuantToMergerAndPrivatePlacementNetOfOfferingCosts
usd
CY2023 patr Issuance Of Series Seed Preferred Stock
IssuanceOfSeriesSeedPreferredStock
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 patr Restricted Stock Awards Liability
RestrictedStockAwardsLiability
usd
CY2022 patr Derivative Liability In Connection With Convertible Note
DerivativeLiabilityInConnectionWithConvertibleNote
usd
CY2022 patr Debt Discount Issued As Accrued Liability
DebtDiscountIssuedAsAccruedLiability
usd
CY2022 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
usd
CY2022 patr Conversion Of Convertible Note And Derivative Into Common Stock In Connection With Merger
ConversionOfConvertibleNoteAndDerivativeIntoCommonStockInConnectionWithMerger
usd
CY2023 patr Subscription Receivable
SubscriptionReceivable
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
usd
CY2023Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001832483
CY2023Q2 dei Entity Public Float
EntityPublicFloat
0 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
patr-20231231_cal.xml Edgar Link unprocessable
0001213900-24-018566-index-headers.html Edgar Link pending
0001213900-24-018566-index.html Edgar Link pending
0001213900-24-018566.txt Edgar Link pending
0001213900-24-018566-xbrl.zip Edgar Link pending
ea0200355-10k_serverobot.htm Edgar Link pending
ea0200355ex10-16_serverobot.htm Edgar Link pending
ea0200355ex10-17_serverobot.htm Edgar Link pending
ea0200355ex10-23_serverobot.htm Edgar Link pending
ea0200355ex10-29_serverobot.htm Edgar Link pending
ea0200355ex10-33_serverobot.htm Edgar Link pending
ea0200355ex31-1_serverobot.htm Edgar Link pending
ea0200355ex31-2_serverobot.htm Edgar Link pending
ea0200355ex32-1_serverobot.htm Edgar Link pending
ea0200355ex32-2_serverobot.htm Edgar Link pending
ea0200355ex4-8_serverobot.htm Edgar Link pending
ea0200355ex97-1_serverobot.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
image_003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
patr-20231231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
patr-20231231_def.xml Edgar Link unprocessable
ea0200355-10k_serverobot_htm.xml Edgar Link completed
patr-20231231_lab.xml Edgar Link unprocessable
patr-20231231_pre.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending